Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research: Jul 21, 2005

Premium
NIH Grants for Pharmacogenomics Research
FY'05 June 13 — July 17
City, State, or Country Name
Organization Name
Principal Investigator
Award
Title
Alabama
Birmingham
University of Alabama at Birmingham Hughes,
Laura B
$107,043
Pharmacogenetics of Methotrexate in Rheumatoid Arthritis
California
San Francisco
University of California, San Francisco Benowitz,
Neal L
$188,512
Clinical Pharmacology, Drug Action, & Pharmacogenetics
San Francisco University of California, San Francisco Giacomini,
Kathleen M
$2,584,827
Pharmacogenetics of Membrane Transporters
San Francisco University of California, San Francisco Szoka,
Francis C
$232,125
Pharmaceutical Sciences and Pharmacogenomics
San Francisco University of California, San Francisco Hauser,
Stephen L
$2,717,681
A Haplotype Map for Multiple Sclerosis
La Jolla University of California, San Diego Nigam,
Sanjay K
$294,525
SNPs in Handling of Small Pox Antivirals & Other Drugs
Los Angeles University of California, Los Angeles Nelson,
Stanley F
$872,727
UCLA NINDS/NIMH Microarray Center
San Diego Veterans Medical Research Foundation, San Diego Patel,
Piyush M
$363,216
Microarray analysis of neuronal ischemic preconditioning
Colorado
Aurora
University of Colorado Denver/HSC Aurora Zahniser,
Nancy R
$112,440
Behavioral Pharmacogenetics of Drug & Alcohol Abuse
Connecticut
New Haven
Yale University Mane,
Shrikant M
$1,245,816
Yale Microarray Center for Research on the Nervous Syste
Florida
Tampa
H. Lee Moffitt Cancer Center and Research Institute Lancaster,
Johnathan M
$81,500
Plasma Microarray Analysis and Ovarian Cancer Biomarkers
Illinois
Chicago
University of Chicago Ratain,
Mark J
$3,000,870
Pharmacogenetics of Anticancer Agents Research Group
Kentucky
Louisville
University of Louisville Hein,
David W
$398,047
Pharmacogenetics of drug and carcinogen metabolism
Maryland
Baltimore
Johns Hopkins University Hidalgo,
Manuel
$297,040
Pharmacogenomics of Erlotinib
Massachussetts
Cambridge
Harvard University Liu, Jun
$326,000
Computational Haplotype Analysis for SNPs
Boston Massachusetts General Hospital Seed, Brian
$785,548
Shared Microarray Facility
Boston Massachusetts General Hospital Thadhani,
Ravi I
$137,500
Antibody Microarray Predicting Pima Diabetic Nephropathy
Minnesota
Rochester
Mayo Clinic College of Medicine, Rochester Weinshilboum, Richard M
$2,460,531
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Rochester Mayo Clinic College of Medicine, Rochester Turner,
Stephen T
$859,934
Anthipertensive PharmacoGenomics
Minneapolis University of Minnesota, Twin Cities Tracy,
Timothy S
$241,600
Pharmacogenetics and Drug Interactions
Missouri
St. Louis
Washington University Mcleod, Howard L
$157,638
Ovarian Cancer Pharmacogenetics
North Carolina
Durham
Duke University Allen,
Andrew S
$142,101
Advanced Haplotype Analyses in Coronary Artery Disease
Durham Duke University Nevins,
Joseph R
$728,625
Functional Microarray Facility
Pennsylvania
Philadelphia
University of Pennsylvania Lerman,
Caryn E
$390,071
Pharmacogenetic Investigation of Naltrexone
Pittsburgh University of Pittsburgh Li, Song
$367,360
Pharmacogenetic Therapy of Pulmonary Hypertension
Texas
San Antonio
University of Texas Health Science Center San Antonio Suh, Yousin
$288,096
Association Analysis of SNPs in Longevity Assurance Gen
Utah
Salt Lake City
LDS Hospital Anderson,
Jeffrey L
$575,237
Risk Burden of Lipoprotein Metabolic Gene Haplotypes
Washington
Seattle
Fred Hutchinson Cancer Research Center Zhao,
Lue Ping
$389,250
Methods for Correlating SNP Haplotypes with Cancer
*SOURCE: US National Institutes of Health

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more